Committee 1 considers the risk of induction of cancer and heritable disease (stochastic effects) together with the underlying mechanisms of radiation action; also, the risks, severity, and mechanisms of induction of tissue/organ damage and developmental defects (deterministic effects).
Committee 1 in Seoul, October 2015 – From left to right back: Quanfu Sun, Dan Stram, Dominique Laurier, Richard Wakeford, Wolfgang Dörr, Andrzej Wojcik, Nobuhiko Ban. From left to right front: Ranajit Chakraborty, Tamara Azizova, Sisko Salomaa, William Morgan (Chair), Simon Bouffler (Vice-Chair), Werner Rühm (Secretary), Michael Hauptmann. Inset: Margot Tirmarche, Preetha Rajaraman.
Summaries of Committee 1 Meetings:
|Helmholtz Zentrum München, Germany|
|French Institute for Radiological Protection and Nuclear Safety (IRSN), France|
|Southern Urals Biophysics Institute, Russian Federation|
|Nuclear Regulation Authority, Japan|
|University of North Texas Health Science Center, USA|
|Med. Univ. Vienna, Dept. Radiotherapy/RadOnc, ATRAB - Applied and Translational Radiobiology, Austria|
|Netherlands Cancer Institute, Netherlands|
|Radiation and Nuclear Safety Authority (STUK), Finland|
|University of Southern California, USA|
|National Institute for Radiological Protection, China|
|Nuclear Safety Authority of France, France|
|The University of Manchester, UK|
|Centre for Radiation Protection Research, Stockholm University, Sweden|